Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$138.96 /

-4.81 (-3.35%)

18:22
02/27/20
02/27
18:22
02/27/20
18:22

Jury orders J&J pay $9M in talc cancer case, Bloomberg reports

A Florida jury has ordered Johnson & Johnson to pay $9M to an 82-year-old woman who claimed that asbestos-tainted talc was responsible for her cancer, Bloomberg's Jef Feeley reports. Jurors in Miami determined that asbestos in baby powder used by Blanca Mure-Cabrera throughout her lifetime contributed to the development of her mesothelioma, Feeley notes, citing one of her lawyers. The trial outcome marks the second loss for J&J this year over claims that it was aware some of its talc-based products were laced with asbestos and concealed it from consumers, the author notes. Reference Link

  • 09

    Mar

  • 10

    Mar

  • 17

    Mar

  • 06

    Apr

  • 14

    Apr

JNJ Johnson & Johnson
$138.96 /

-4.81 (-3.35%)

01/27/20 Credit Suisse
Johnson & Johnson price target raised to $170 from $163 at Credit Suisse
01/21/20 SVB Leerink
SVB Leerink bearish on Arrowhead, initiates with an Underperform
01/10/20 BWS Financial
Anika acquisitions set up direct competition with partner, says BWS Financial
01/09/20 JMP Securities
Argenx price target raised to $170 from $164 at JMP Securities

TODAY'S FREE FLY STORIES

Upgrade
Sherwin-Williams upgraded to Conviction Buy from Neutral at Goldman Sachs » 05:41
03/30/20
03/30
05:41
03/30/20
05:41
SHW

Sherwin-Williams

$461.17 /

-3.92 (-0.84%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Republic Services upgraded to Overweight from Neutral at JPMorgan » 05:38
03/30/20
03/30
05:38
03/30/20
05:38
RSG

Republic Services

$75.45 /

-2.14 (-2.76%)

JPMorgan analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
ING Group suspends dividend payment due to COVID-19 » 05:35
03/30/20
03/30
05:35
03/30/20
05:35
ING

ING Group

$6.04 /

-0.44 (-6.79%)

ING provided the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Mondelez upgraded to Buy from Hold at Stifel » 05:35
03/30/20
03/30
05:35
03/30/20
05:35
MDLZ

Mondelez

$47.61 /

-0.93 (-1.92%)

Stifel analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Regeneron, Sanofi announce first patient outside U.S. treated in Kevzara study » 05:33
03/30/20
03/30
05:33
03/30/20
05:33
REGN

Regeneron

$448.05 /

-4.26 (-0.94%)

, SNY

Sanofi

$42.47 /

-0.48 (-1.12%)

Regeneron Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
GFL Environmental initiated with a Buy at Stifel » 05:31
03/30/20
03/30
05:31
03/30/20
05:31
GFL

GFL Environmental

$14.95 /

-0.09 (-0.60%)

Stifel analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Carbo Ceramics to be acquired by Wilks Brothers » 05:30
03/30/20
03/30
05:30
03/30/20
05:30
CRR

Carbo Ceramics

$0.00 /

+ (+0.00%)

CARBO Ceramics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Magellan Midstream upgraded to Buy from Underperform at BofA » 05:29
03/30/20
03/30
05:29
03/30/20
05:29
MMP

Magellan Midstream

$33.53 /

-0.92 (-2.67%)

BofA analyst Derek Walker…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
International Paper agrees to sell Brazilian corrugated packaging business » 05:28
03/30/20
03/30
05:28
03/30/20
05:28
IP

International Paper

$30.60 /

-0.45 (-1.45%)

International Paper has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Moderna provides update on COVID-19 impact » 05:27
03/30/20
03/30
05:27
03/30/20
05:27
MRNA

Moderna

$30.01 /

+2.1 (+7.52%)

Moderna provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Polaris Industries downgraded to Market Perform from Outperform at BMO Capital » 05:26
03/30/20
03/30
05:26
03/30/20
05:26
PII

Polaris Industries

$47.25 /

-5.545 (-10.50%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
NeoPhotonics upgraded to Overweight from Neutral at Piper Sandler » 05:23
03/30/20
03/30
05:23
03/30/20
05:23
NPTN

NeoPhotonics

$6.72 /

-0.045 (-0.67%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
AstraZeneca says FARXIGA reduced incidence of heart failure worsening » 05:23
03/30/20
03/30
05:23
03/30/20
05:23
AZN

AstraZeneca

$42.56 /

+0.26 (+0.61%)

New data from a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Cleveland-Cliffs reinstated with a Neutral at Goldman Sachs » 05:20
03/30/20
03/30
05:20
03/30/20
05:20
CLF

Cleveland-Cliffs

$3.79 /

-0.1 (-2.57%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Stelco Holdings downgraded to Sell from Neutral at Goldman Sachs » 05:18
03/30/20
03/30
05:18
03/30/20
05:18
STZHF

Stelco Holdings

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Reliance Steel upgraded to Buy from Neutral at Goldman Sachs » 05:16
03/30/20
03/30
05:16
03/30/20
05:16
RS

Reliance Steel

$83.41 /

-8.04 (-8.79%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Nucor upgraded to Buy from Neutral at Goldman Sachs » 05:15
03/30/20
03/30
05:15
03/30/20
05:15
NUE

Nucor

$32.95 /

-0.3 (-0.90%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Nektar upgraded to Neutral from Sell at Goldman Sachs » 05:09
03/30/20
03/30
05:09
03/30/20
05:09
NKTR

Nektar

$17.26 /

-0.25 (-1.43%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Hermes upgraded to Neutral from Sell at Goldman Sachs » 05:07
03/30/20
03/30
05:07
03/30/20
05:07
HESAY

Hermes

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Syneos Health downgraded to Neutral from Buy at Goldman Sachs » 05:04
03/30/20
03/30
05:04
03/30/20
05:04
SYNH

Syneos Health

$41.41 /

-2.51 (-5.71%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Atco upgraded to Outperform from Market Perform at BMO Capital » 05:00
03/30/20
03/30
05:00
03/30/20
05:00
ACLLF

Atco

$0.00 /

+ (+0.00%)

BMO Capital analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Fortis upgraded to Outperform from Market Perform at BMO Capital » 04:58
03/30/20
03/30
04:58
03/30/20
04:58
FTS

Fortis

$35.52 /

-1.2 (-3.27%)

BMO Capital analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Emera upgraded to Outperform from Market Perform at BMO Capital » 04:56
03/30/20
03/30
04:56
03/30/20
04:56
EMRAF

Emera

$0.00 /

+ (+0.00%)

BMO Capital analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Hydro One upgraded to Outperform from Market Perform at BMO Capital » 04:55
03/30/20
03/30
04:55
03/30/20
04:55
HRNNF

Hydro One

$0.00 /

+ (+0.00%)

BMO Capital analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Cantor Fitzgerald biopharma analysts to hold analyst/industry conference call » 04:55
03/30/20
03/30
04:55
03/30/20
04:55
MRK

Merck

$71.62 /

-1.77 (-2.41%)

, LLY

Eli Lilly

$134.03 /

-0.55 (-0.41%)

, MRTX

Mirati Therapeutics

$76.30 /

-3.96 (-4.93%)

, INCY

Incyte

$68.89 /

-4.21 (-5.76%)

Specialty Pharma Analyst…

Specialty Pharma Analyst Chen, Biotech Analysts Young and Kumar and Biopharma Analyst Folkes, along with Dr. Marron, MD, PhD and Asst Professor at Mt. Sinai Health System, reviews the current treatment paradigm for 1L NSCLC (Non-Small Cell Lung Cancer) on an Analyst/Industry conference call to be held on March 30 at 1 pm.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.